Kirby Turner, PA
Surgical · Smithtown, NYNPI 1023680626
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,826 of the $18,012 with a category attached, or 65.7%. 29 manufacturers reported payments, led by Boston Scientific at 51.7% of the total. 2025 is the largest year on record at $11,209, more than ten times the $208 reported in 2022. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 437 payments — averaging $41.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$9K
- Collegium Pharmaceutical, Inc.$2K
- Medtronic$2K
- AbbVie$1K
- Relievant Medsystems, Inc.$687
- Valinor Pharma, LLC$662
- plus $3K from 23 others
What the payments were for
- Speaking & faculty fees$2,79015%
- Travel & lodging$3,39719%
- Food & beverage$11,82666%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 64 | $9,305 |
| Collegium Pharmaceutical, Inc. | 164 | $1,552 |
| Medtronic | 22 | $1,547 |
| AbbVie | 57 | $1,395 |
| Relievant Medsystems, Inc. | 8 | $687 |
| Valinor Pharma, LLC | 65 | $662 |
| Nalu Medical, Inc. | 7 | $661 |
| Vertos Medical, Inc. | 2 | $301 |
| Forte Bio-pharma LLC | 7 | $285 |
| Biotronik NRO, Inc. | 4 | $270 |
| MML US, Inc. | 3 | $203 |
| Averitas Pharma Inc. | 3 | $191 |
| Lundbeck LLC | 4 | $162 |
| Pfizer | 3 | $124 |
| Tonix Medicines, Inc. | 1 | $94 |
| Vertex | 2 | $90 |
| Nevro Corp. | 3 | $77 |
| Painteq LLC | 1 | $70 |
| Stryker | 3 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Orexo US, Inc. | 2 | $37 |
| Protega Pharmaceutials Inc | 2 | $37 |
| Bioventus LLC | 1 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Globus Medical | 1 | $24 |
| IBSA Pharma Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $18 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WaveWriter Alpha Prime 16$6,482
- Intracept$3,009
- Prolate$600
- GENERAL PAIN MANAGEMENT$595
- INCEPTIV$575
- INTELLIS ADAPTIVESTIM$548
- Nalu Neurostimulation System$529
- UBRELVY$359
- mild Device Kit$301
- QULIPTA$250
- Superion Indirect Decompression System$173
- Prospera$170
- Nalocet$150
- Qutenza$139
- ReActiv8$129
- VYEPTI$109
How this compares
$18,012 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 41 | $39,040 |
| RelistorMethylnaltrexone Bromide | 12 | $27,293 |
| MovantikNaloxegol Oxalate | 43 | $16,557 |
| OxycontinOxycodone Hcl | 24 | $14,820 |
| Diclofenac Sodium | 73 | $11,562 |
| Lidocaine | 46 | $5,105 |
| Pregabalin | 109 | $4,859 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 201 | $4,127 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 130 | $3,178 |
| Oxycodone Hcl | 136 | $2,712 |
| Gabapentin | 226 | $2,320 |
| Fentanyl | 23 | $1,526 |
| Celecoxib | 42 | $1,339 |
| Morphine Sulfate ErMorphine Sulfate | 46 | $941 |
| Methocarbamol | 43 | $812 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $1,552 | $39,04041 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $45 | $27,29312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,544 surgical providers in New York.
Other surgical in Smithtown
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Tanya GeistAmherst$43K
- Irina KommNew York$39K
- Sarah MartineckWilliamsville$34K
- Richard DalabaAlbany$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.